Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 646, pseudogene (RN7SL646P) is one of hundreds of human 7SL RNA-derived pseudogenes, which are genome-inserted copies of 7SL RNA formed by reverse transcription and integration. The original 7SL RNA is a crucial non-coding RNA component of the signal recognition particle, mediating the cotranslational translocation of proteins across membranes. Pseudogenes like RN7SL646P are generally thought to be non-functional remnants, though some pseudogenes have been shown to have regulatory roles in gene expression, such as acting as miRNA sponges or participating in epigenetic mechanisms. However, there is no evidence that RN7SL646P specifically is involved in any biological processes, disease, or therapeutic interactions.
None (pseudogene, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 646, pseudogene (RN7SL646P).